BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22958460)

  • 1. Investigation of volatile organic biomarkers derived from Plasmodium falciparum in vitro.
    Wong RP; Flematti GR; Davis TM
    Malar J; 2012 Sep; 11():314. PubMed ID: 22958460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volatile organic compounds associated with Plasmodium falciparum infection in vitro.
    Correa R; Coronado LM; Garrido AC; Durant-Archibold AA; Spadafora C
    Parasit Vectors; 2017 May; 10(1):215. PubMed ID: 28464853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volatile metabolites differentiate air-liquid interface cultures after infection with
    Ahmed W; Bardin E; Davis MD; Sermet-Gaudelus I; Grassin Delyle S; Fowler SJ
    Analyst; 2023 Jan; 148(3):618-627. PubMed ID: 36597770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of breath sampling methods: a post hoc analysis from observational cohort studies.
    Berna AZ; Schaber CL; Bollinger LB; Mwale M; Mlotha-Mitole R; Trehan I; Odom John AR
    Analyst; 2019 Mar; 144(6):2026-2033. PubMed ID: 30702091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breathprinting Reveals Malaria-Associated Biomarkers and Mosquito Attractants.
    Schaber CL; Katta N; Bollinger LB; Mwale M; Mlotha-Mitole R; Trehan I; Raman B; Odom John AR
    J Infect Dis; 2018 Apr; 217(10):1553-1560. PubMed ID: 29415208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
    De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
    J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid method for breath analysis in cystic fibrosis patients.
    Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Breath Specimens for Biomarkers of Plasmodium falciparum Infection.
    Berna AZ; McCarthy JS; Wang RX; Saliba KJ; Bravo FG; Cassells J; Padovan B; Trowell SC
    J Infect Dis; 2015 Oct; 212(7):1120-8. PubMed ID: 25810441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Proton Transfer Reaction-Mass Spectrometry and electronic nose study of the volatile compounds released by Plasmodium falciparum infected red blood cells in vitro.
    Capuano R; Khomenko I; Grasso F; Messina V; Olivieri A; Cappellin L; Paolesse R; Catini A; Ponzi M; Biasioli F; Di Natale C
    Sci Rep; 2019 Aug; 9(1):12360. PubMed ID: 31451707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors that influence the volatile organic compound content in human breath.
    Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
    J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological variability in volatile organic compounds (VOCs) in exhaled breath and released from faeces due to nutrition and somatic growth in a standardized caprine animal model.
    Fischer S; Trefz P; Bergmann A; Steffens M; Ziller M; Miekisch W; Schubert JS; Köhler H; Reinhold P
    J Breath Res; 2015 May; 9(2):027108. PubMed ID: 25971714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution metabolomics to discover potential parasite-specific biomarkers in a Plasmodium falciparum erythrocytic stage culture system.
    Park YH; Shi YP; Liang B; Medriano CA; Jeon YH; Torres E; Uppal K; Slutsker L; Jones DP
    Malar J; 2015 Mar; 14():122. PubMed ID: 25889340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic collection and analysis of volatile organic compounds from the headspace of cell cultures.
    Baranska A; Smolinska A; Boots AW; Dallinga JW; van Schooten FJ
    J Breath Res; 2015 Oct; 9(4):047102. PubMed ID: 26469548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of volatile organic compounds for the classification and identification of mycobacterial species.
    Küntzel A; Oertel P; Fischer S; Bergmann A; Trefz P; Schubert J; Miekisch W; Reinhold P; Köhler H
    PLoS One; 2018; 13(3):e0194348. PubMed ID: 29558492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.
    Shestivska V; Dryahina K; Nunvář J; Sovová K; Elhottová D; Nemec A; Smith D; Španěl P
    J Breath Res; 2015 Apr; 9(2):027104. PubMed ID: 25830686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.